Actinogen Medical
Andrew Udell is an accomplished executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as the Chief Commercial Officer at Actinogen Medical, Andrew has previously held significant leadership roles, including President and Head of North America at Calliditas Therapeutics AB, and Vice President of US Commercial. Andrew also served as Vice President of Commercial for Neuroderm and operates their own consulting firm, Andrew B. Udell Consulting LLC, where Andrew is the Principal. Andrew's background reflects a strong focus on commercial strategy and leadership in the North American market.
This person is not in any teams
This person is not in any offices
Actinogen Medical
1 followers
FOCUSED ON DEVELOPING AN INNOVATIVE TREATMENT FOR COGNITIVE IMPAIRMENT due to raised cortisol ASSOCIATED WITH NEUROLOGICAL DISEASES Ethics Committee approval for XanaMIA StudyActinogen has received approval from the Bellberry Human Research Ethics Comm...